Organisation

ESACT2024 Organising Committee

Alan Dickson

University of Manchester, UK (Chair, ESACT2024)

Nicole Borth

BOKU, Austria

Jonathan Dempsey

Pathway Biopharma, UK

Joanne Flannelly

University of Manchester, UK

Laura Kuhner

Kuhner Ag, Switzerland

Glenn Robinson

Getinge, UK

Mark Smales

University of Kent, UK

Chris van der Walle

Cell & Gene Therapy Catapult, UK

ESACT2024 Scientific Committee

Mark Smales

University of Kent, UK (Chair, Scientific Committee)

Christina Alves

Takeda, USA

Paula Alves

iBET and ITQB NOVA Universidade de Lisboa, Portugal

Niall Barron

DCU and NIBRT, Ireland

Mike Betenbaugh

John Hopkins WSE, USA

Simon Fischer

Boehringer Ingelheim, Germany

Chetan Goudar

Amgen, USA

Stefanos Grammatikos

UCB, Belgium

Laura Palomares

IBT-UNAM, Mexico

Susan Rosser

University of Edinburgh, UK

Matthieu Stettler

Cytiva, Switzerland

Anne Tolstrup

AbtBioConsult, Denmark

Till Wenger

Boehringer Ingelheim, Germany

ESACT Executive Committee

Nicole Borth

BOKU, Austria (Chair)

Stefanos Grammatikos

UCB, Belgium (Vice-Chair)

Anne Tolstrup

AbtBioConsult, Denmark (Secretary)

Francesc Gòdia

UAB, Spain (Treasurer)

Niall Barron

DCU and NIBRT, Ireland

Paulo Fernandes

Orchard Therapeutics, UK

Emma Petiot

CPE-Lyon Engineer School, France

António Roldão

IBET, Portugal

ESACT 2024 BEGINS

Scroll to Top